M&A

Royalty Pharma plans to tap Elan investors on offer -source

Royalty Pharma plans to tap Elan investors on offer -source

Reuters

Royalty Pharma proposes $6.6 bln bid for Elan

Royalty Pharma proposes $6.6 bln bid for Elan

Reuters

Elan Armed With Biogen Billions Hunts for Deals: Real M&A

Elan Armed With Biogen Billions Hunts for Deals: Real M&A

Bloomberg

Cubist Announces Exclusive Option to Acquire Adynxx

Cubist Announces Exclusive Option to Acquire Adynxx

Yahoo

Endo Health new CEO suggests near-term sale unlikely, says Wells Fargo

Endo Health new CEO suggests near-term sale unlikely, says Wells Fargo

The Fly on the Wall

China Biotech Week In Review: Regeneron Pharma, Bayer Start New Trial For DME Treatment

China Biotech Week In Review: Regeneron Pharma, Bayer Start New Trial For DME Treatment

Seeking Alpha

BGI-Shenzhen Extends Tender Offer For Complete Genomics, inc.

BGI-Shenzhen Extends Tender Offer For Complete Genomics, inc.

Yahoo/PR Newswire

Bausch & Lomb Owner Said to Seek Banks for IPO as Sale Falters

Bausch & Lomb Owner Said to Seek Banks for IPO as Sale Falters

Bloomberg

InterMune Sale Looms as Lung Drug Nears FDA Nod: Real M&A

InterMune Sale Looms as Lung Drug Nears FDA Nod: Real M&A

Bloomberg

Biomarin: This Mid-Cap Pharmaceutical is a Prime Takeover Target

Biomarin: This Mid-Cap Pharmaceutical is a Prime Takeover Target

Motley Fool